Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$784M |
| 2 |
Apple
AAPL
|
+$427M |
| 3 |
Danaher
DHR
|
+$417M |
| 4 |
Prologis
PLD
|
+$405M |
| 5 |
Amazon
AMZN
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$587M |
| 2 |
Eli Lilly
LLY
|
+$491M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$343M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$252M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Open Text
OTEX
$6.04B
| $32.4M | ﹤0.01% |
1,089,132
+4,577
| +0.4% | +$130K |
|
1452
Carpenter Technology
CRS
$28.4B
| $32.3M | ﹤0.01% |
875,710
+32,546
| +4% | +$1.24M |
|
1453
Cohen & Steers
CNS
$4.3B
| $32.3M | ﹤0.01% |
500,396
+4,192
| +0.8% | +$263K |
|
1454
CRISPR Therapeutics
CRSP
$5.17B
| $32.1M | ﹤0.01% |
789,098
+24,422
| +3% | +$1.3M |
|
|
MRTX
1455
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $32M | ﹤0.01% |
707,345
+51,395
| +8% | +$3.33M |
|
1456
Brookfield Asset Management
BAM
$83.8B
| $32M | ﹤0.01% |
+1,109,648
| New | +$33.4M |
|
1457
ESAB
ESAB
$5.71B
| $32M | ﹤0.01% |
681,164
+83,952
| +14% | +$3.51M |
|
1458
Frontdoor
FTDR
$6.26B
| $32M | ﹤0.01% |
1,536,218
+21,217
| +1% | +$466K |
|
|
RCM
1459
DELISTED
R1 RCM Inc. Common Stock
RCM
| $31.9M | ﹤0.01% |
2,915,627
+103,582
| +4% | +$1.31M |
|
1460
Chewy
CHWY
$9.63B
| $31.9M | ﹤0.01% |
862,209
+35,730
| +4% | +$1.39M |
|
1461
SiTime
SITM
$21.8B
| $31.9M | ﹤0.01% |
313,986
+12,595
| +4% | +$1.19M |
|
1462
BancFirst
BANF
$3.8B
| $31.9M | ﹤0.01% |
361,836
+14,939
| +4% | +$1.41M |
|
1463
TriCo Bancshares
TCBK
$1.83B
| $31.9M | ﹤0.01% |
624,945
+26,013
| +4% | +$1.36M |
|
|
ELME
1464
Elme Communities
ELME
$144M
| $31.9M | ﹤0.01% |
1,789,399
+61,419
| +4% | +$1.13M |
|
1465
Lindsay Corp
LNN
$1.18B
| $31.8M | ﹤0.01% |
195,472
+7,749
| +4% | +$1.28M |
|
1466
Materion
MTRN
$6.04B
| $31.8M | ﹤0.01% |
363,465
+12,055
| +3% | +$984K |
|
|
DOOR
1467
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $31.8M | ﹤0.01% |
394,011
+15,396
| +4% | +$1.14M |
|
1468
Helios Technologies
HLIO
$2.76B
| $31.7M | ﹤0.01% |
581,907
+22,588
| +4% | +$1.22M |
|
|
GAP
1469
The Gap Inc
GAP
$7.37B
| $31.7M | ﹤0.01% |
2,808,064
+124,677
| +5% | +$1.49M |
|
1470
Pricesmart
PSMT
$5.46B
| $31.6M | ﹤0.01% |
520,490
+4,828
| +0.9% | +$315K |
|
1471
John Wiley & Sons Class A
WLY
$2.66B
| $31.6M | ﹤0.01% |
787,995
+25,393
| +3% | +$1.06M |
|
1472
Amylyx Pharmaceuticals
AMLX
$2.54B
| $31.6M | ﹤0.01% |
853,913
+218,357
| +34% | +$7.75M |
|
1473
MYR Group
MYRG
$5.25B
| $31.5M | ﹤0.01% |
342,244
+2,004
| +0.6% | +$182K |
|
1474
Arvinas
ARVN
$572M
| $31.3M | ﹤0.01% |
914,294
+30,169
| +3% | +$1.27M |
|
1475
Oceaneering
OII
$4.77B
| $31.2M | ﹤0.01% |
1,786,292
+69,317
| +4% | +$921K |
|
Similar funds
Geode Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Geode Capital Management held 5,090 positions worth $713B, up 8.1% from $659B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 4.9%. Geode Capital Management opened 62 new positions and exited 188, leaving the 5,090-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2022 buy was Ferguson: 1,854,192 shares worth $235M.
- Geode Capital Management added most to Microsoft in Q4 2022, an estimated $784M increase.
- Geode Capital Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $491M.
- Geode Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $587M.
- Geode Capital Management's ten largest holdings make up 20% of its $713B portfolio in Q4 2022.
- Geode Capital Management opened 62 new positions and closed 188 in Q4 2022.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $713B.
Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.